Development and Optimization of Solid Lipid Nanoparticles for Improved Antifungal Efficacy
International Journal of Drug Delivery Technology · 02.06.2026 · 16 (44s)
DOI: 10.25258/ijddt.16.44s.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 02.06.2026. Verfasst von Ritesh Raj und 6 weiteren Autor:innen.
Abstract (Originalsprache)
The therapeutic effectiveness of antifungal agents is often limited by poor aqueous solubility, low bioavailability, and insufficient penetration into infected tissues. Solid lipid nanoparticles (SLNs) have emerged as a promising drug delivery system to overcome these limitations by enhancing drug stability, controlled release, and targeted delivery. The present study focuses on the development and systematic optimization of SLNs encapsulating a model antifungal agent to improve its therapeutic efficacy. SLNs were prepared using a high-shear homogenization followed by ultrasonication method, employing biocompatible lipids and surfactants. Critical formulation variables, including lipid concentration, surfactant type, and homogenization parameters, were optimized using a design of experiments (DoE) approach to achieve minimal particle size, high drug loading, and optimal stability. The optimized formulation exhibited a particle size below 200 nm, narrow polydispersity index, and high entrapment efficiency, indicating uniform and stable nanoparticle formation. In vitro release studies demonstrated a sustained drug release profile over 24 hours, which is advantageous for prolonged antifungal activity. Furthermore, antifungal efficacy studies against Candida albicans revealed significantly enhanced inhibition compared to the conventional drug formulation, attributed to improved cellular uptake and prolonged drug exposure. Stability studies confirmed that the SLNs maintained their physicochemical properties under standard storage conditions. Overall, the findings highlight that SLNs provide an efficient platform for enhancing antifungal drug delivery by improving solubility, stability, and bioavailability. This study establishes a robust formulation and optimization framework that can be extended to other poorly soluble antifungal agents. The integration of nanotechnology-based delivery systems such as SLNs holds substantial promise for improving clinical outcomes in the treatment of fungal infections.
Zitieren
APA
Raj, R., Kumar, A., Sahu, A., Mandlekar, R., Chaturvedi, P., Uikey, L., & Patel, N. (2026). Development and Optimization of Solid Lipid Nanoparticles for Improved Antifungal Efficacy. International Journal of Drug Delivery Technology, 16(44s). https://doi.org/10.25258/ijddt.16.44s.1
Vancouver
Raj R, Kumar A, Sahu A, Mandlekar R, Chaturvedi P, Uikey L, et al. Development and Optimization of Solid Lipid Nanoparticles for Improved Antifungal Efficacy. International Journal of Drug Delivery Technology. 2026;16(44s). doi:10.25258/ijddt.16.44s.1
BibTeX
@article{Raj2026,
author = {Raj, Ritesh and Kumar, Ajay and Sahu, Abhishek and Mandlekar, Ranu and Chaturvedi, Prasant and Uikey, Lalita and Patel, Nitin},
title = {Development and Optimization of Solid Lipid Nanoparticles for Improved Antifungal Efficacy},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {44s},
doi = {10.25258/ijddt.16.44s.1}
}
EUVIMED